Home Articles List Article Information
Egyptian Journal of Botany
Journal Archive
Volume Volume 65 (2025)
Volume Volume 64 (2024)
Volume Volume 63 (2023)
Volume Volume 62 (2022)
Volume Volume 61 (2021)
Volume Volume 60 (2020)
Volume Volume 59 (2019)
Volume Volume 58 (2018)
Volume Volume 57 (2017)
Volume Volume 56 (2016)
Volume Volume 55 (2015)
Volume Volume 54 (2014)
El-adly, A., Shabana, I. (2018). Antimicrobial Activity of Green Silver Nanoparticles against Fluconazole-resistant Candida albicans in Animal Model. Egyptian Journal of Botany, 58(1), 119-132. doi: 10.21608/ejbo.2018.1292.1110
Amira El-adly; Iman Shabana. "Antimicrobial Activity of Green Silver Nanoparticles against Fluconazole-resistant Candida albicans in Animal Model". Egyptian Journal of Botany, 58, 1, 2018, 119-132. doi: 10.21608/ejbo.2018.1292.1110
El-adly, A., Shabana, I. (2018). 'Antimicrobial Activity of Green Silver Nanoparticles against Fluconazole-resistant Candida albicans in Animal Model', Egyptian Journal of Botany, 58(1), pp. 119-132. doi: 10.21608/ejbo.2018.1292.1110
El-adly, A., Shabana, I. Antimicrobial Activity of Green Silver Nanoparticles against Fluconazole-resistant Candida albicans in Animal Model. Egyptian Journal of Botany, 2018; 58(1): 119-132. doi: 10.21608/ejbo.2018.1292.1110

Antimicrobial Activity of Green Silver Nanoparticles against Fluconazole-resistant Candida albicans in Animal Model

Article 11, Volume 58, Issue 1, April 2018, Page 119-132  XML PDF (1.17 MB)
Document Type: Regular issue (Original Article)
DOI: 10.21608/ejbo.2018.1292.1110
View on SCiNiTO View on SCiNiTO
Authors
Amira El-adly email 1; Iman Shabana2
1Laser Microbiology Laboratory, National Institute of Laser Enhanced Science, Cairo University, Cairo, Egypt
2Faculty of Veterinary Medicine, Department of Bacteriology, Immunology and Mycology, Suez Canal University, Ismailia, Egypt
Abstract
FUNGAL infections due to fluconazole-resistant Candida albicans are a serious clinical problem, requiring new efficient antifungal treatment. The present study evaluated the susceptibility of fluconazole-resistant C. albicans to green silver nanoparticles. A total of 40 isolates were examined for the expressions of CDR1, CDR2, and MDR1 gene by quantitative reverse transcription polymerase chain reaction. The antifungal activities of green silver nanoparticles alone and/or in combination with fluconazole (to improve antifungal activity) were assessed by broth microdilution assay and transmission electron microscopy. The effect of fluconazole and/or green silver nanoparticles on the production of C. albicans to protease and phospholipase was also evaluated. And finally, animal model was used to prove the safe and effective use of green silver nanoparticles in the treatment of fluconazole-resistant C. albicans. For all the tested C. albicans strains, the minimum inhibitory concentrations (MICs) of fluconazole and green silver nanoparticles were 64 and 4.84 μg/ml, respectively. Green silver nanoparticles decrease the production of protease and phospholipase enzymes. The expression of both CDR1 and CDR2 were decreased after exposure to green silver nanoparticles, while the expression of CDR 1, CDR 2 and MDR 1 were all decreased when fluconazole and green silver nanoparticles were used. Green silver nanoparticles may be causing suppression of the CDR1, CDR2 and MDR1 expression in fluconazole-resistant C. albicans. The results suggest the use of green silver nanoparticles as a safe and effective treatment against fluconazole-resistant C. albicans.
Keywords
<i> Candida albicans </i>; Fluconazole resistance; Green silver nanoparticles
Statistics
Article View: 741
PDF Download: 1,199